Ludwig Kiesel

No ORCID on file · 125 papers in corpus
article 2004
·doi:10.1240/sav_gbm_2004_h_000761
article 2003
·doi:10.1055/s-2003-815264

Zielsetzung: Im eutopen Endometrium bestehen erhebliche menstruationszyklusabhängige Fluktuationen der Angiogenese, ein Prozess, der auch bei der Entstehung von Endometrioseläsionen beobachtet wird. Wir untersuchten hier den Einfluss hormon…

article 2003
·doi:10.1016/s0015-0282(03)01503-6
review 2003
Drugs of today (Barcelona, Spain : 1998) ·doi:10.1358/dot.2003.39.12.799414

Endometriosis is a multifactorial disease affecting up to 15% of women of reproductive age. This condition is characterized by the presence and growth of endometrial cells outside the uterus. Susceptibility to endometriosis depends on compl…

article 2003
·doi:10.1016/s0015-0282(03)01519-x
article 2002
·doi:10.1055/s-2002-33719

Der Zusammenhang zwischen der Ausprägung der Endometriose, der Lokalisation im Bereich des kleinen Beckens und dem klinischen Erscheinungsbild ist immer noch unklar. Das Ziel der vorliegenden Arbeit ist es, die Ausdehnung sowie die typische…

article 2002
·doi:10.1007/s00129-002-1177-5
article 2002
·doi:10.1016/s0015-0282(01)03068-0
article 2002
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/gye.16.6.493.504

(2002). Molecular mechanisms contributing to the pathogenesis of endometriosis. Gynecological Endocrinology: Vol. 16, No. 6, pp. 493-504.

article 2002
·doi:10.1080/713603163

Click to increase image sizeClick to decrease image sizeENDOMETRIOSIS PATHOGENESIS CYTOKINES HOX ANGIOGENESIS

article 2001
·doi:10.1055/s-2001-18367

Die Erkrankung Endometriose stellt sowohl in Bezug auf die noch unvollständig geklärte Entstehung und Pathogenese, als auch im Hinblick auf die diagnostische Beurteilung und adäquate Therapie eine große Herausforderung dar. Im eutopen Endom…

article 2001
Fertility and Sterility ·doi:10.1016/s0015-0282(00)01642-3

ObjectiveTo investigate microvessel density in adenomyosis compared to the endometrium in patients with adenomyosis and in normal controls.DesignUterine paraffin-embedded histologic specimens were immunostained for CD34. The area with the h…

article 2000
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.85.7.6665

Our laboratories have focused recently on the production and localization of eotaxin, a C-C-chemokine of 8.4 kDa, whose major biological activity is the chemoattraction of eosinophils. Given evidence of autoimmune activity in the endometrio…

article 1999

The assessment of the activity of endometriosis provides a challenge during endoscopic procedures. Novel approaches can be developed in future based on more detailed understanding of the mechanisms of the pathogenesis of endometriosis. Angi…

article 1996
British journal of obstetrics and gynaecology

Add-back hormone replacement therapy has been shown to alleviate some of the hypo-oestrogenic side effects associated with gonadotrophin-releasing hormone agonists, including demineralisation of bone. Studies on patients with uterine fibroi…

article 1993
·doi:10.1007/bf02266107
book-chapter 1993
·doi:10.1007/978-3-642-77857-5_215
book-chapter 1992
·doi:10.1007/978-3-642-45683-1_16
book-chapter 1992
·doi:10.1007/978-3-642-77666-3_2
article 1990
Progress in clinical and biological research
article 1989
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-68-6-1167

We studied the pharmacokinetics of iv and intranasally administered buserelin, a LHRH agonist peptide, in 14 women with endometriosis. Serum and urinary buserelin concentrations were determined by specific RIA (buserelin antiserum AS-639). …

book-chapter 1989
·doi:10.1007/978-3-642-74784-7_482
article 1989
Archives of gynecology and obstetrics ·doi:10.1007/bf02417628

In a randomized study, the effect of gestrinone (2 x 2.5 mg/week) was compared with the effect of danazol (3 x 200 mg/day) in treating 30 patients with laparoscopically proven endometriotic implants for 6 months. Therapy was effective in 80…

article 1984

In vivo, a single dose of 1000 mg danazol was given orally to pregnant volunteers (n = 8) prior to a therapeutic abortion (8th-12th week of gestation). Changes in serum progesterone and estradiol were evaluated both by analysis of percentag…

article 1983
·doi:10.1016/s0015-0282(16)47295-x

In vitro, danazol showed a slight dose-dependent inhibition of the mitochondrial cholesterol side chain cleavage enzyme isolated from early gestational (8th to 12th week of gestation) placenta. In the presence of 100 microM danazol, the enz…